PA-22-176, sbir, phase I, novel bispecific nanotherapeutics as broad-spectrum influenza antivirals refractory to viral escape

Ended Cooperative Agreement Awarded Last action

Award ID
R43IP001224
Recipient
Awarding agency
Obligated
$899,382

Award facts

Assistance listing
93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance
Completion date
Originally
Funding agency
Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
San Diego, CA, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $299,794
Amendment $299,794
Original award $299,794
Show all 13

Quick answers

Who received award R43IP001224?

R43IP001224 was awarded to Eitr Biologics, Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2023.

How much is award R43IP001224 worth?

$899,382 has been obligated on R43IP001224.

Which agency awarded R43IP001224?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001224, with funding from Office of the Director (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award